CD40LG and ischemic stroke: A study underscored the association between elevated levels of specific inflammatory mediators, such as CD40 ligand (CD40L) and monocyte chemoattractant protein‐1 (MCP‐1), and the risk of long‐term nonfatal vascular events in ischemic stroke patients [8].